Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg vs Placebo in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension

NCT00532558 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00532558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00532558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg vs Placebo in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2007
Completion date
May 31, 2008
Enrollment
657 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia